News & Media

News

November 9, 2023

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

COLUMBUS, OH, Nov 9, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

News

October 20, 2023

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

COLUMBUS, OH, OCTOBER 20, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

Play video
News & Media

June 22, 2023

Cell and Gene Therapy CDMO Andelyn Biosciences Celebrates Over 20 Years of Leadership and Innovation with Opening of New 180,000 Square Foot Manufacturing Headquarters

Columbus, Ohio – June 22, 2023 – Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene...

News & Media

March 27, 2023

Andelyn Biosciences Announce New Chief Commercial Officer

(COLUMBUS, Ohio) – Andelyn Biosciences announces the appointment of Matt Niloff as Chief Commercial Officer (CCO). Niloff will lead the...

News & Media

March 8, 2023

Inspiring the Next Generation of Women in Life Sciences

In honor of International Women's Day, EPM brings you an exclusive roundup of inspiring commentary from over 25 empowering women in the STEM and life sciences industries. These women share their personal experiences of working in these fields, the challenges they face, and their tips for encouraging young women who are wishing to pursue a career in STEM.

News & Media

March 1, 2023

Andelyn Biosciences Board of Directors Announce New CEO

(COLUMBUS, Ohio) – Andelyn Biosciences Chief Operations Officer Wade Macedone has been promoted to CEO of the gene and cell...

Blog

February 18, 2023

Suspension Cell Culture in Cell and Gene Therapy

The Growing Demand for Suspension Cell Culture Platforms The biopharmaceutical sector is growing and demand for viral vectors as tools...

Blog

February 18, 2023

Genetic Engineering

Delivering Genetic Editing Therapies to Market In the past 10 years, our understanding of molecular biology and genetic engineering has...

News & Media

February 1, 2023

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...

Blog

November 28, 2022

Trends in AAV development and manufacturing for gene therapies

Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...

Connect Here With Our Business Team